← Leaderboards
Hong Wen
Van Andel Research Institute
$3,004,575
Attributed
$4,274,986
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $985.8K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,274,986 · 2
By mechanism
R01$4,274,986 · 2
Top collaborators
- Jian Jin5 shared
Most similar at Van Andel Research Institute
Same institution · by research overlap
- Xiaobing Shi$3,739,848
- Derek Henry Janssens$384,480
Others in their field
Other Emerging Leaders on “Innovation”
- Klaus Romero · Critical Path Institute$86,053,372
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$69,953,681
- Tony Moody · Duke University$65,625,959
- Matthew Johnson · Duke University$60,590,296
Research focus
InnovationInfantGene RearrangementGrowthHistone AcetylationHistonesEvolutionGene ExpressionGene TranslocationComplexDriver MutationEffective TherapyHistone H3Histone MethyltransferaseAcute Myelocytic LeukemiaChromatinFutureCellsBiochemicalChromosomal TranslocationChildhood LeukemiaBiophysicsAcute Lymphocytic LeukemiaIn Vitro
Grant awards (9)
Development of Novel PROTACs Targeting the ENL YEATS Domain for Treating MLL-rearranged Leukemias$514,092
R01 · FY2025 · CA
Development of Novel PROTACs Targeting the ENL YEATS Domain for Treating MLL-rearranged Leukemias$488,387
R01 · FY2024 · CA
Discovery of small molecules targeting the histone acetylation reader ENL$408,872
R01 · FY2024 · CA · contact PI
Development of Novel PROTACs Targeting the ENL YEATS Domain for Treating MLL-rearranged Leukemias$503,120
R01 · FY2023 · CA
Discovery of small molecules targeting the histone acetylation reader ENL$431,498
R01 · FY2023 · CA · contact PI
Development of Novel PROTACs Targeting the ENL YEATS Domain for Treating MLL-rearranged Leukemias$503,533
R01 · FY2022 · CA
Discovery of small molecules targeting the histone acetylation reader ENL$439,725
R01 · FY2022 · CA · contact PI
Development of Novel PROTACs Targeting the ENL YEATS Domain for Treating MLL-rearranged Leukemias$531,691
R01 · FY2021 · CA
Discovery of small molecules targeting the histone acetylation reader ENL$454,068
R01 · FY2021 · CA · contact PI